PGRMC2 and HLA-G regulate immune homeostasis in a microphysiological model of human maternal-fetal membrane interface.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
23 Aug 2024
Historique:
received: 13 02 2024
accepted: 15 08 2024
medline: 24 8 2024
pubmed: 24 8 2024
entrez: 23 8 2024
Statut: epublish

Résumé

Chorion trophoblasts (CTCs) and immune cell-enriched decidua (DECs) comprise the maternal-fetal membrane interface called the chorio-decidual interface (CDi) which constantly gets exposed to maternal stressors without leading to labor activation. This study explored how CTCs act as a barrier at CDi. The roles of human leukocyte antigen (HLA)-G and progesterone receptor membrane component 2 (PGRMC2) in mediating immune homeostasis were also investigated. The CDi was recreated in a two-chamber microfluidic device (CDi-on-chip) with an outer chamber of primary DECs and immune cell line-derived innate immune cells and an inner chamber of wild-type or PGRMC2 or HLA-G knockout immortalized CTCs. To mimic maternal insults, DECs were treated with lipopolysaccharide, poly(I:C), or oxidative stress inducer cigarette smoke extract. Expression levels of inflammation and immunity genes via targeted RNA sequencing, production of soluble mediators, and immune cell migration into CTCs were determined. In CDi-on-chip, decidua and immune cells became inflammatory in response to insults while CTCs were refractory, highlighting their barrier function. HLA-G and PGRMC2 are found to be vital to immune homeostasis at the CDi, with PGRMC2 serving as an upstream regulator of inflammation, HLA-G expression, and mesenchymal-epithelial transition, and HLA-G serving as a frontline immunomodulatory molecule, thus preventing fetal membrane compromise.

Identifiants

pubmed: 39179795
doi: 10.1038/s42003-024-06740-2
pii: 10.1038/s42003-024-06740-2
doi:

Substances chimiques

HLA-G Antigens 0
Receptors, Progesterone 0
Membrane Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1041

Subventions

Organisme : U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (NCATS)
ID : UH3TR003283-03
Organisme : U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (NCATS)
ID : UH2TR004117-01

Informations de copyright

© 2024. The Author(s).

Références

Gomez-Lopez, N., StLouis, D., Lehr, M. A., Sanchez-Rodriguez, E. N. & Arenas-Hernandez, M. Immune cells in term and preterm labor. Cell Mol. Immunol. 11, 571–581 (2014).
pubmed: 24954221 pmcid: 4220837 doi: 10.1038/cmi.2014.46
Vidal, M. S., Lintao, R. C. V., Severino, M. E. L., Tantengco, O. A. G. & Menon, R. Spontaneous preterm birth: involvement of multiple feto-maternal tissues and organ systems, differing mechanisms, and pathways. Front. Endocrinol. 13, 1015622 (2022).
doi: 10.3389/fendo.2022.1015622
Menon, R., Richardson, L. S. & Lappas, M. Fetal membrane architecture, aging and inflammation in pregnancy and parturition. Placenta 79, 40–45 (2019).
pubmed: 30454905 doi: 10.1016/j.placenta.2018.11.003
Menon, R. & Moore, J. J. Fetal membranes, not a mere appendage of the placenta, but a critical part of the fetal-maternal interface controlling parturition. Obstet. Gynecol. Clin. North Am. 47, 147–162 (2020).
pubmed: 32008665 doi: 10.1016/j.ogc.2019.10.004
Kammala, A. K. et al. Expression of CYP450 enzymes in human fetal membranes and its implications in xenobiotic metabolism during pregnancy. Life Sci. 307, 120867 (2022).
pubmed: 35940219 doi: 10.1016/j.lfs.2022.120867
Aye, I. L., Paxton, J. W., Evseenko, D. A. & Keelan, J. A. Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes. Placenta 28, 868–877 (2007).
pubmed: 17482262 doi: 10.1016/j.placenta.2007.03.001
Ganguly, E. et al. Organic anion transporting polypeptide 2B1 in human fetal membranes: a novel gatekeeper for drug transport during pregnancy? Front. Pharm. 12, 771818 (2021).
doi: 10.3389/fphar.2021.771818
Kammala, A., Benson, M., Ganguly, E., Richardson, L. & Menon, R. Functional role and regulation of permeability-glycoprotein (P-gp) in the fetal membrane during drug transportation. Am. J. Reprod. Immunol. 87, e13515 (2022).
pubmed: 34873775 doi: 10.1111/aji.13515
Kammala, A. et al. Fetal membranes contribute to drug transport across the feto-maternal interface utilizing the breast cancer resistance protein (BCRP). Life 12, https://doi.org/10.3390/life12020166 (2022).
Lintao, R. C. V., Kammala, A. K., Vora, N., Yaklic, J. L. & Menon, R. Fetal membranes exhibit similar nutrient transporter expression profiles to the placenta. Placenta 135, 33–42 (2023).
pubmed: 36913807 doi: 10.1016/j.placenta.2023.03.001
Ramuta, T., Šket, T., Starčič Erjavec, M. & Kreft, M. E. Antimicrobial activity of human fetal membranes: from biological function to clinical use. Front. Bioeng. Biotechnol. 9, 691522 (2021).
pubmed: 34136474 pmcid: 8201995 doi: 10.3389/fbioe.2021.691522
Menon, R., Behnia, F., Polettini, J. & Richardson, L. S. Novel pathways of inflammation in human fetal membranes associated with preterm birth and preterm pre-labor rupture of the membranes. Semin. Immunopathol. 42, 431–450 (2020).
pubmed: 32785751 pmcid: 9296260 doi: 10.1007/s00281-020-00808-x
Jacobs, S. O. et al. Characterizing the immune cell population in the human fetal membrane. Am. J. Reprod. Immunol. 85, e13368 (2021).
pubmed: 33145922 doi: 10.1111/aji.13368
Poisner, A. M., Wood, G. W., Poisner, R. & Inagami, T. Localization of renin in trophoblasts in human chorion laeve at term pregnancy. Endocrinology 109, 1150–1155 (1981).
pubmed: 7026220 doi: 10.1210/endo-109-4-1150
Van Meir, C. A. et al. Immunoreactive 15-hydroxyprostaglandin dehydrogenase (PGDH) is reduced in fetal membranes from patients at preterm delivery in the presence of infection. Placenta 17, 291–297 (1996).
pubmed: 8829211 doi: 10.1016/S0143-4004(96)90052-1
King, A. E., Kelly, R. W., Sallenave, J. M., Bocking, A. D. & Challis, J. R. Innate immune defences in the human uterus during pregnancy. Placenta 28, 1099–1106 (2007).
pubmed: 17664005 doi: 10.1016/j.placenta.2007.06.002
Bukowski, R. et al. Onset of human preterm and term birth is related to unique inflammatory transcriptome profiles at the maternal fetal interface. PeerJ 5, e3685 (2017).
pubmed: 28879060 pmcid: 5582610 doi: 10.7717/peerj.3685
Lozovyy, V., Richardson, L., Saade, G. & Menon, R. Progesterone receptor membrane components: key regulators of fetal membrane integrity. Biol. Reprod. 104, 445–456 (2021).
pubmed: 33048113 doi: 10.1093/biolre/ioaa192
Marsh B., Zhou Y., Kapidzic M., Fisher S., Blelloch R. Regionally distinct trophoblast regulate barrier function and invasion in the human placenta. Elife 11, https://doi.org/10.7554/eLife.78829 (2022).
Richardson, L. et al. A microphysiological device to model the choriodecidual interface immune status during pregnancy. J. Immunol. 210, 1437–1446 (2023).
pubmed: 36920387 doi: 10.4049/jimmunol.2200821
Zaga-Clavellina, V. et al. In vitro secretion profiles of interleukin (IL)-1beta, IL-6, IL-8, IL-10, and TNF alpha after selective infection with Escherichia coli in human fetal membranes. Reprod. Biol. Endocrinol. 5, 46 (2007).
pubmed: 18078521 pmcid: 2175507 doi: 10.1186/1477-7827-5-46
Merlino, A. et al. Nuclear progesterone receptor expression in the human fetal membranes and decidua at term before and after labor. Reprod. Sci. 16, 357–363 (2009).
pubmed: 19196877 doi: 10.1177/1933719108328616
Kumar, D. et al. Progesterone inhibits in vitro fetal membrane weakening. Am. J. Obstet. Gynecol. 213, 520.e1–9 (2015).
pubmed: 26070709 doi: 10.1016/j.ajog.2015.06.014
Feng, L. et al. Progesterone receptor membrane component 1 (PGRMC1) expression in fetal membranes among women with preterm premature rupture of the membranes (PPROM). Placenta 35, 331–333 (2014).
pubmed: 24680695 doi: 10.1016/j.placenta.2014.03.008
Richardson L. S., Taylor R. N., Menon R. Reversible EMT and MET mediate amnion remodeling during pregnancy and labor. Sci. Signal. 13, https://doi.org/10.1126/scisignal.aay1486 (2020).
Kapałczyńska, M. et al. 2D and 3D cell cultures - a comparison of different types of cancer cell cultures. Arch. Med. Sci. 14, 910–919 (2018).
pubmed: 30002710
Fortunato, S. J., Menon, R., Swan, K. F. & Lyden, T. W. Organ culture of amniochorionic membrane in vitro. Am. J. Reprod. Immunol. 32, 184–187 (1994).
pubmed: 7880402 doi: 10.1111/j.1600-0897.1994.tb01112.x
Pereira, P. N. et al. Amnion formation in the mouse embryo: the single amniochorionic fold model. BMC Dev. Biol. 11, 48 (2011).
pubmed: 21806820 pmcid: 3163621 doi: 10.1186/1471-213X-11-48
Carter, A. M. IFPA Senior Award Lecture: mammalian fetal membranes. Placenta 48, S21–S30 (2016).
pubmed: 26518719 doi: 10.1016/j.placenta.2015.10.012
Downs K. M., Rodriguez A. M. The mouse fetal-placental arterial connection: a paradigm involving the primitive streak and visceral endoderm with implications for human development. Wiley Interdiscip. Rev. Dev. Biol. 9, e362. https://doi.org/10.1002/wdev.362 (2020).
Chuva de Sousa Lopes, S. M., Roelen, B. A. J., Lawson, K. A. & Zwijsen, A. The development of the amnion in mice and other amniotes. Philos. Trans. R. Soc. Lond. B Biol. Sci. 377, 20210258 (2022).
pubmed: 36252226 pmcid: 9574641 doi: 10.1098/rstb.2021.0258
Richardson, L., Kim, S., Menon, R. & Han, A. Organ-on-chip technology: the future of feto-maternal interface research? Front. Physiol. 11, 715 (2020).
pubmed: 32695021 pmcid: 7338764 doi: 10.3389/fphys.2020.00715
Richardson, L., Jeong, S., Kim, S., Han, A. & Menon, R. Amnion membrane organ-on-chip: an innovative approach to study cellular interactions. FASEB J. 33, 8945–8960 (2019).
pubmed: 31039044 pmcid: 6662977 doi: 10.1096/fj.201900020RR
Radnaa, E. et al. Generation and characterization of human fetal membrane and decidual cell lines for reproductive biology experiments†. Biol. Reprod. 106, 568–582 (2022).
pubmed: 34935931 doi: 10.1093/biolre/ioab231
Kaur, G. & Dufour, J. M. Cell lines: valuable tools or useless artifacts. Spermatogenesis 2, 1–5 (2012).
pubmed: 22553484 pmcid: 3341241 doi: 10.4161/spmg.19885
Mosebarger, A. et al. Immune cells at the feto-maternal interface: comprehensive characterization and insights into term labor. J. Reprod. Immunol. 163, 104239 (2024).
pubmed: 38493591 doi: 10.1016/j.jri.2024.104239
Radnaa, E. et al. Extracellular vesicle mediated feto-maternal HMGB1 signaling induces preterm birth. Lab. Chip 21, 1956–1973 (2021).
pubmed: 34008619 pmcid: 8162392 doi: 10.1039/D0LC01323D
Richardson, L. S., Kim, S., Han, A. & Menon, R. Modeling ascending infection with a feto-maternal interface organ-on-chip. Lab. Chip 20, 4486–4501 (2020).
pubmed: 33112317 pmcid: 7815379 doi: 10.1039/D0LC00875C
Richardson, L. S. et al. Development of oxidative stress-associated disease models using feto-maternal interface organ-on-a-chip. FASEB J. 37, e23000 (2023).
pubmed: 37249377 doi: 10.1096/fj.202300531R
Wang, W., Sung, N., Gilman-Sachs, A. & Kwak-Kim, J. T Helper (Th) cell profiles in pregnancy and recurrent pregnancy losses: Th1/Th2/Th9/Th17/Th22/Tfh cells. Front. Immunol. 11, 2025 (2020).
pubmed: 32973809 pmcid: 7461801 doi: 10.3389/fimmu.2020.02025
Martín-Villa, J. M. et al. HLA-G: too much or too little? Role in cancer and autoimmune disease. Front. Immunol. 13, 796054 (2022).
pubmed: 35154112 pmcid: 8829012 doi: 10.3389/fimmu.2022.796054
Sahay, A., Kale, A. & Joshi, S. Role of neurotrophins in pregnancy and offspring brain development. Neuropeptides 83, 102075 (2020).
pubmed: 32778339 doi: 10.1016/j.npep.2020.102075
McCormick, J., Whitley, G. S., Le Bouteiller, P. & Cartwright, J. E. Soluble HLA-G regulates motility and invasion of the trophoblast-derived cell line SGHPL-4. Hum. Reprod. 24, 1339–1345 (2009).
pubmed: 19223288 doi: 10.1093/humrep/dep026
Kumar, D. et al. Decidual GM-CSF is a critical common intermediate necessary for thrombin and TNF induced in-vitro fetal membrane weakening. Placenta 35, 1049–1056 (2014).
pubmed: 25454284 doi: 10.1016/j.placenta.2014.10.001
Favaron, P. O., Carvalho, R. C., Borghesi, J., Anunciação, A. R. & Miglino, M. A. The amniotic membrane: development and potential applications—a review. Reprod. Domest. Anim. 50, 881–892 (2015).
pubmed: 26510939 doi: 10.1111/rda.12633
Joyce, E. M. et al. In-vivo stretch of term human fetal membranes. Placenta 38, 57–66 (2016).
pubmed: 26907383 doi: 10.1016/j.placenta.2015.12.011
Sindram-Trujillo, A. P. et al. Comparison of decidual leukocytes following spontaneous vaginal delivery and elective cesarean section in uncomplicated human term pregnancy. J. Reprod. Immunol. 62, 125–137 (2004).
pubmed: 15288188 doi: 10.1016/j.jri.2003.11.007
Sharkey, A. M. et al. Tissue-specific education of decidual NK cells. J. Immunol. 195, 3026–3032 (2015).
pubmed: 26320253 pmcid: 4574523 doi: 10.4049/jimmunol.1501229
Flores-Espinosa, P. et al. Immunomodulatory role of decidual prolactin on the human fetal membranes and placenta. Front. Immunol. 14, 1212736 (2023).
pubmed: 37359537 pmcid: 10288977 doi: 10.3389/fimmu.2023.1212736
Goldman, B., Radnaa, E., Kechichian, T. & Menon, R. Silencing P38 MAPK reduces cellular senescence in human fetal chorion trophoblast cells. Am. J. Reprod. Immunol. 89, e13648 (2023). Jan.
pubmed: 36334089 doi: 10.1111/aji.13648
Yang L., et al. Innate immune signaling in trophoblast and decidua organoids defines differential antiviral defenses at the maternal-fetal interface. Elife 11, https://doi.org/10.7554/eLife.79794 (2022).
Hackmon R., et al. Definitive class I human leukocyte antigen expression in gestational placentation: HLA-F, HLA-E, HLA-C, and HLA-G in extravillous trophoblast invasion on placentation, pregnancy, and parturition. Am. J. Reprod. Immunol. 77, https://doi.org/10.1111/aji.12643 (2017).
Koga, K. & Mor, G. Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am. J. Reprod. Immunol. 63, 587–600 (2010).
pubmed: 20367625 pmcid: 3025804 doi: 10.1111/j.1600-0897.2010.00848.x
Romero, R., Mazor, M., Manogue, K., Oyarzun, E. & Cerami, A. Human decidua: a source of cachectin-tumor necrosis factor. Eur. J. Obstet. Gynecol. Reprod. Biol. 41, 123–127 (1991).
pubmed: 1936492 doi: 10.1016/0028-2243(91)90089-4
Gómez-Chávez, F. et al. NF-κB and its regulators during pregnancy. Front. Immunol. 12, 679106 (2021).
pubmed: 34025678 pmcid: 8131829 doi: 10.3389/fimmu.2021.679106
Menon, R. Fetal inflammatory response at the fetomaternal interface: a requirement for labor at term and preterm. Immunol. Rev. 308, 149–167 (2022).
pubmed: 35285967 pmcid: 9188997 doi: 10.1111/imr.13075
Glover, A. V. & Manuck, T. A. Screening for spontaneous preterm birth and resultant therapies to reduce neonatal morbidity and mortality: a review. Semin. Fetal Neonatal Med. 23, 126–132 (2018).
pubmed: 29229486 doi: 10.1016/j.siny.2017.11.007
Pru, J. K. & Clark, N. C. PGRMC1 and PGRMC2 in uterine physiology and disease. Front. Neurosci. 7, 168 (2013).
pubmed: 24065879 pmcid: 3776937 doi: 10.3389/fnins.2013.00168
Castelli, E. C. et al. Insights into HLA-G genetics provided by worldwide haplotype diversity. Front. Immunol. 5, 476 (2014).
pubmed: 25339953 pmcid: 4186343 doi: 10.3389/fimmu.2014.00476
Amodio, G. & Gregori, S. HLA-G genotype/expression/disease association studies: success, hurdles, and perspectives. Front. Immunol. 11, 1178 (2020).
pubmed: 32733439 pmcid: 7360675 doi: 10.3389/fimmu.2020.01178
Xu, X., Zhou, Y. & Wei, H. Roles of HLA-G in the maternal-fetal immune microenvironment. Front. Immunol. 11, 592010 (2020).
pubmed: 33193435 pmcid: 7642459 doi: 10.3389/fimmu.2020.592010
Rouas-Freiss, N. et al. Role of the HLA-G immune checkpoint molecule in pregnancy. Hum. Immunol. 82, 353–361 (2021).
pubmed: 33745758 doi: 10.1016/j.humimm.2021.01.003
Barbaro G., et al. HLA-G and recurrent pregnancy loss. Int. J. Mol. Sci. 24, https://doi.org/10.3390/ijms24032557 (2023).
Aisagbonhi, O. & Morris, G. P. Human leukocyte antigens in pregnancy and preeclampsia. Front Genet 13, 884275 (2022).
pubmed: 35571013 pmcid: 9093604 doi: 10.3389/fgene.2022.884275
Tantengco, O. A. G. et al. Histocompatibility antigen, class I, G (HLA-G)‘s role during pregnancy and parturition: a systematic review of the literature. Life 11, https://doi.org/10.3390/life11101061 (2021).
Lin, A. & Yan, W. H. Perspective of HLA-G induced immunosuppression in SARS-CoV-2 infection. Front. Immunol. 12, 788769 (2021).
pubmed: 34938296 pmcid: 8685204 doi: 10.3389/fimmu.2021.788769
Ferreira, L. M. R., Meissner, T. B., Tilburgs, T. & Strominger, J. L. HLA-G: at the interface of maternal-fetal tolerance. Trends Immunol. 38, 272–286 (2017).
pubmed: 28279591 doi: 10.1016/j.it.2017.01.009
Dunk, C. E. et al. Human leukocyte antigen HLA-C, HLA-G, HLA-F, and HLA-E placental profiles are altered in early severe preeclampsia and preterm birth with chorioamnionitis. Am. J. Obstet. Gynecol. 227, 641.e1–641.e13 (2022).
pubmed: 35863458 doi: 10.1016/j.ajog.2022.07.021
Kusanovic, J. P. et al. Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation. J. Matern. Fetal Neonatal Med. 22, 1151–1166 (2009).
pubmed: 19916713 pmcid: 3424396 doi: 10.3109/14767050903019684
Krop, J. et al. Soluble HLA-G blood levels are not increased during ongoing pregnancy in women with a history of recurrent pregnancy loss. J. Reprod. Immunol. 153, 103665 (2022).
pubmed: 35905658 doi: 10.1016/j.jri.2022.103665
Cappelletti, M., Presicce, P. & Kallapur, S. G. Immunobiology of acute chorioamnionitis. Front. Immunol. 11, 649 (2020).
pubmed: 32373122 pmcid: 7177011 doi: 10.3389/fimmu.2020.00649
Park, J. Y. et al. A microphysiological model of human trophoblast invasion during implantation. Nat. Commun. 13, 1252 (2022).
pubmed: 35292627 pmcid: 8924260 doi: 10.1038/s41467-022-28663-4
Bonney, E. A. & Johnson, M. R. The role of maternal T cell and macrophage activation in preterm birth: cause or consequence? Placenta 79, 53–61 (2019).
pubmed: 30929747 pmcid: 7377276 doi: 10.1016/j.placenta.2019.03.003
Boddy, A. M., Fortunato, A., Wilson Sayres, M. & Aktipis, A. Fetal microchimerism and maternal health: a review and evolutionary analysis of cooperation and conflict beyond the womb. Bioessays 37, 1106–1118 (2015).
pubmed: 26316378 pmcid: 4712643 doi: 10.1002/bies.201500059
Green, E. S. & Arck, P. C. Pathogenesis of preterm birth: bidirectional inflammation in mother and fetus. Semin. Immunopathol. 42, 413–429 (2020).
pubmed: 32894326 pmcid: 7508962 doi: 10.1007/s00281-020-00807-y
Millius, A. & Weiner, O. D. Manipulation of neutrophil-like HL-60 cells for the study of directed cell migration. Methods Mol. Biol. 591, 147–158 (2010).
pubmed: 19957129 pmcid: 3128798 doi: 10.1007/978-1-60761-404-3_9
Starr, T., Bauler, T. J., Malik-Kale, P. & Steele-Mortimer, O. The phorbol 12-myristate-13-acetate differentiation protocol is critical to the interaction of THP-1 macrophages with Salmonella Typhimurium. PLoS One 13, e0193601 (2018).
pubmed: 29538403 pmcid: 5851575 doi: 10.1371/journal.pone.0193601
Liu, Y. et al. Changes of inhibitory receptors on NK-92 cells and HLA-G on BeWo cells with Toxoplasma gondii infection. Inflammation 36, 1440–1447 (2013).
pubmed: 23872718 doi: 10.1007/s10753-013-9684-1
Montaldo, E. et al. Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor. Blood 119, 3987–3996 (2012).
pubmed: 22403260 doi: 10.1182/blood-2011-09-379693
Montaldo, E. et al. Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and function. Cytometry A 83, 702–713 (2013).
pubmed: 23650273 doi: 10.1002/cyto.a.22302
Zhang, C., Zhang, J., Niu, J., Zhou, Z. & Tian, Z. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D. Hum. Immunol. 69, 490–500 (2008).
pubmed: 18619507 doi: 10.1016/j.humimm.2008.06.004
Peng, Q., Vijaya Satya, R., Lewis, M., Randad, P. & Wang, Y. Reducing amplification artifacts in high multiplex amplicon sequencing by using molecular barcodes. BMC Genom. 16, 589 (2015).
doi: 10.1186/s12864-015-1806-8
Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).
pubmed: 34557778 pmcid: 8454663

Auteurs

Ryan C V Lintao (RCV)

Division of Basic Science and Translational Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.
Department of Biochemistry and Molecular Biology, College of Medicine, University of the Philippines Manila, Manila, Philippines.
Institute of Reproductive Health, National Institutes of Health, University of the Philippines Manila, Manila, Philippines.

Lauren S Richardson (LS)

Division of Basic Science and Translational Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.

Ananth Kumar Kammala (AK)

Division of Basic Science and Translational Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.

Jenieve Chapa (J)

Division of Basic Science and Translational Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.

Dianne Aster Yunque-Yap (DA)

Department of Pharmacology and Toxicology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.
Microbiome and Bioinformatics Analysis Core, The Institute for Translational Sciences, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.
National Aeronautics and Space Administration Johnson Space Center, Houston, TX, USA.
KBR, Houston, TX, USA.

Kamil Khanipov (K)

Department of Pharmacology and Toxicology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.
Microbiome and Bioinformatics Analysis Core, The Institute for Translational Sciences, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.

George Golovko (G)

Department of Pharmacology and Toxicology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.
Microbiome and Bioinformatics Analysis Core, The Institute for Translational Sciences, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.

Leslie Michelle M Dalmacio (LMM)

Department of Biochemistry and Molecular Biology, College of Medicine, University of the Philippines Manila, Manila, Philippines.

Ramkumar Menon (R)

Division of Basic Science and Translational Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA. ra2menon@utmb.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH